Product Description: D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy[1].
Formula: C13H14N2O3
References: [1]F Lepage, et al. New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur JMed Chem (1992) 27,581-593.
CAS Number: 130403-18-8
Molecular Weight: 246.26
Research Area: Neurological Disease
Target: Endogenous Metabolite